Pharma ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer By Angus Liu Jun 2, 2024 8:00am ASCO 2024 Enhertu breast cancer antibody drug conjugates ...

Daiichi Sankyo will hold a virtual conference call for investors on Monday, June 3, 2024 from 6:00 to 7:00 pm CDT / Tuesday, June 4, 2024 from 8:00 to 9:00 am JST.

Daiichi Sankyo will hold a virtual conference call for investors on Monday, June 2, 2025 from 6:00 to 7:15 pm CDT / Tuesday, June 3, 2025 from 8:00 to 9:15 am JST.

Daiichi Sankyo Continues to Transform Treatment Landscape for Patients with Cancer with Practice-Changing Data at ASCO Late-breaking data from DESTINY-Breast09 and DESTINY-Gastric04 phase 3 trials ...